Rapid Identification of New Biomarkers for the Classification of GM1 Type 2 Gangliosidosis Using an Unbiased 1H NMR-Linked Metabolomics Strategy

Abstract

Biomarkers currently available for the diagnosis, prognosis, and therapeutic monitoring of GM1 gangliosidosis type 2 (GM1T2) disease are mainly limited to those discovered in targeted proteomic-based studies. In order to identify and establish new, predominantly low-molecular-mass biomarkers for this disorder, we employed an untargeted, multi-analyte approach involving high-resolution 1H NMR analysis coupled to a range of multivariate analysis and computational intelligence technique (CIT) strategies to explore biomolecular distinctions between blood plasma samples collected from GM1T2 and healthy control (HC) participants (n = 10 and 28, respectively). The relationship of these differences to metabolic mechanisms underlying the pathogenesis of GM1T2 disorder was also investigated. 1H NMR-linked metabolomics analyses revealed significant GM1T2-mediated dysregulations in ≥13 blood plasma metabolites (corrected p < 0.04), and these included significant upregulations in 7 amino acids, and downregulations in lipoprotein-associated triacylglycerols and alanine. Indeed, results acquired demonstrated a profound distinctiveness between the GM1T2 and HC profiles. Additionally, employment of a genome-scale network model of human metabolism provided evidence that perturbations to propanoate, ethanol, amino-sugar, aspartate, seleno-amino acid, glutathione and alanine metabolism, fatty acid biosynthesis, and most especially branched-chain amino acid degradation (p = 10−12−10−5) were the most important topologically-highlighted dysregulated pathways contributing towards GM1T2 disease pathology. Quantitative metabolite set enrichment analysis revealed that pathological locations associated with these dysfunctions were in the order fibroblasts > Golgi apparatus > mitochondria > spleen ≈ skeletal muscle ≈ muscle in general. In conclusion, results acquired demonstrated marked metabolic imbalances and alterations to energy demand, which are consistent with GM1T2 disease pathogenesis mechanisms.

Mathematical modeling for freshness/spoilage of chicken breast using chemometric analysis

“…By calculating the weighted sum of the PLS regression coefficients, we identified significant buckets with the most outstanding contribution to cluster segregation in PLS-DA, and assigned their metabolites ( Moreno-Barea et al, 2022 ). The RF technique combines many decision trees constructed by classifying each tree and voting for popular classes by bootstrap sampling ( Percival et al, 2021 ). The number of trees selected was 5000 ( Gandhi et al, 2022 ).…”

A Journey towards Understanding the Molecular Pathology and Developing Therapies for Lysosomal Storage Disorders

“…For monitoring the effect of such therapy trials, biomarkers that can provide a quantitative assessment of the treatment effect are required. Percival et al describe a novel strategy for the identification of new biomarkers for GM1 type 2 gangliosidosis, with a nuclear magnetic resonance (NMR)-linked metabolomics strategy [ 13 ]. The development of such methods for further LSD is of high importance, as they also facilitate diagnosis and may identify novel metabolic targets for therapy interventions.…”